服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-FOLR1 mAbs [Farletuzumab Biosimilar] (MABL-4699) | MABL-4699 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Fasinumab Biosimilar] (MABL-4700) | MABL-4700 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-LAG3/CD223 mAbs [Favezelimab Biosimilar] (MABL-4701) | MABL-4701 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-KLB;FGFR1/CD331/BFGFR mAbs [Fazpilodemab Biosimilar] (MABL-4702) | MABL-4702 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-ICOS/CD278 mAbs [Feladilimab Biosimilar] (MABL-4703) | MABL-4703 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VTCN1/B7H4 mAbs [Felmetatug Biosimilar] (MABL-4704) | MABL-4704 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADPRC1/CD38 mAbs [Felzartamab Biosimilar] (MABL-4705) | MABL-4705 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-EREG mAbs [Fepixnebart Biosimilar] (MABL-4706) | MABL-4706 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL22 mAbs [Fezakinumab Biosimilar] (MABL-4707) | MABL-4707 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-LAG3/CD223 mAbs [Fianlimab Biosimilar] (MABL-4708) | MABL-4708 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Ficerafusp Biosimilar] (MABL-4709) | MABL-4709 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADPRC1/CD38 mAbs [Erzotabart Biosimilar] (MABL-4676) | MABL-4676 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD8 mAbs [Etakafusp Biosimilar] (MABL-4677) | MABL-4677 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MAPT mAbs [Etalanetug Biosimilar] (MABL-4678) | MABL-4678 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ITGAVB3/CD61/VNR mAbs [Etaracizumab Biosimilar] (MABL-4679) | MABL-4679 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Etentamig Biosimilar] (MABL-4680) | MABL-4680 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Etesevimab Biosimilar] (MABL-4681) | MABL-4681 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1;CD3E mAbs [Etevritamab Biosimilar] (MABL-4682) | MABL-4682 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Etigilimab Biosimilar] (MABL-4683) | MABL-4683 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL13 mAbs [Etokimab Biosimilar] (MABL-4684) | MABL-4684 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn